ARTICLE | Clinical News
Sublinox edluar regulatory update
August 1, 2011 7:00 AM UTC
Health Canada approved an NDS for Sublinox zolpidem for short-term treatment and symptomatic relief of insomnia. Meda Valeant Pharma Canada Inc, a JV between Meda and partner Valeant Pharmaceuticals ...